logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Bliss GVS Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    506197
    INE416D01022
    97.2265068
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    BLISSGVS
    18.28
    1483.09
    EPS(TTM)
    Face Value()
    Div & Yield %:
    7.7
    1
    0.35
     
Quadrant Televentures Ltd
Quadrant Televentures reports standalone net loss of Rs 164.97 crore in the December 2024 quarter
Feb 13,2025
Net Loss of Quadrant Televentures reported to Rs 164.97 crore in the quarter ended December 2024 as against net loss of Rs 27.63 crore during the previous quarter ended December 2023. Sales declined 10.18% to Rs 58.33 crore in the quarter ended December 2024 as against Rs 64.94 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales58.3364.94 -10
OPM %15.1615.29 -
PBDT-24.62-22.23 -11
PBT-29.65-27.63 -7
NP-164.97-27.63 -497